Search Results

The evolution of immune dysfunction in multiple myeloma.

• Authors : Soekojo, Cinnie Yentia (AUTHOR); Chng, Wee Joo (AUTHOR)

Subjects: MULTIPLE myeloma; IMMUNE system; DRUG resistance

• Source: European Journal of Haematology. Nov2022, Vol. 109 Issue 5, p415-424. 10p.

Record details

Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.

• Authors : Frassanito, Maria Antonia; Ruggieri, Simona; Desantis, Vanessa

Subjects: T cells; ANTIGEN presenting cells; MULTIPLE myeloma treatment

• Source: European Journal of Haematology. Jul2015, Vol. 95 Issue 1, p65-74. 10p.

Record details

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

• Authors : Allegra, Alessandro; Penna, Giuseppa; Alonci, Andrea

Subjects: MULTIPLE myeloma; IMMUNOGLOBULINS; MONOCLONAL antibodies

• Source: European Journal of Haematology. Jun2013, Vol. 90 Issue 6, p441-468. 28p. 4 Charts.

Record details

Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.

• Authors : Hongyan Tong; Yanling Ren; Fengjuan Zhang

Subjects: APOPTOSIS; BIOMOLECULES; PROTEIN-tyrosine kinases

• Source: European Journal of Haematology. Oct2008, Vol. 81 Issue 4, p259-266. 8p. 2 Black and White Photographs, 3 Graphs.

Record details

The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.

• Authors : Baśkiewicz-Masiuk, Magdalena; Machaliński, Bogustaw

Subjects: LEUKEMIA genetics; HEMATOPOIETIC stem cell transplantation; PROTEINS

• Source: European Journal of Haematology. Jun2004, Vol. 72 Issue 6, p420-429. 10p.

Record details

Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.

• Authors : Kyrtsonis, Maria-Christina; Vassilakopoulos, Theodoros P.; Siakantaris, Marina P.

Subjects: MULTIPLE myeloma; DISEASES; DRUG therapy

• Source: European Journal of Haematology. Apr2004, Vol. 72 Issue 4, p252-258. 7p.

Record details

Constitutive activation of STAT transcription factors in acute myelogenous leukemia.

• Authors : Spiekermann, K.; Biethahn, S.; Wilde, S.

Subjects: TRANSCRIPTION factors; ACUTE myeloid leukemia; HEMATOPOIETIC growth factors

• Source: European Journal of Haematology; Aug2001, Vol. 67 Issue 2, p63-71, 9p

Record details

Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.

• Authors : Abildgaard, N.; Glerup, H.; Rungby, J.

Subjects: BONE metabolism; BIOMARKERS; MULTIPLE myeloma

• Source: European Journal of Haematology; Feb2000, Vol. 64 Issue 2, p121-129, 9p

Record details

Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma.

• Authors : Abildgaard, N.; Rungby, J.; Glerup, H.

• Source: European Journal of Haematology; Aug1998, Vol. 61 Issue 2, p128-134, 7p

Record details

Investigation of megakaryopoiesis in myelosuppressed bone marrow using immunogold-silver staining (IGSS).

• Authors : Selig, Christoph; Kreja, Ludwika; Nothdurft, Wilhelm

• Source: European Journal of Haematology; May1996, Vol. 56 Issue 5, p293-300, 8p

Record details